29.07.2015
- French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...
16.07.2015
- French drugmaker Sanofi has announced plans to streamline its corporate structure with effect from January 2016. The company pointed to its heritage formed from a combination of...
10.07.2015
- Sanofi has announced plans to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria. The...
09.07.2015
- Bayer CropScience and Evonik have now officially quantified their plans for a co-investment at Evonik’s production site in Mobile, Alabama, USA. Together with Evonik, the US...
25.06.2015
- Christopher Viehbacher, former CEO of Sanofi, has been named managing partner of US-based Gurnet Point Capital. The $2 billion healthcare investment fund belongs to the Waypoint...
18.06.2015
- Sandoz, Inc., the US arm of Novartis’ generic drugs division, is asking the Supreme Court of the US state of Mississippi to reverse a county court’s $38.2 million judgment against...
29.04.2015
- The European Commission has granted marketing authorization in Europe for Sanofi's Toujeo, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus...
28.04.2015
- Sweden's Moberg Pharma has acquired US over-the-counter drugmaker Balmex from Chattem, the US consumer healthcare division of French pharmaceutical producer Sanofi, for $3.9...
